Literature DB >> 19222104

Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis.

Jung-Wook Huh1, Young-Jin Kim, Hyeong-Rok Kim.   

Abstract

A 68-year-old man underwent laparoscopic low anterior resection for rectal carcinoma in December 2006. Nearly 19 mo after the operation, he developed recurrent rectal cancer with peritoneal metastasis. In September 2008, he subsequently underwent a laparotomy with a peritonectomy, omentectomy, splenectomy, and a Hartmann procedure. Hyperthermic intraperitoneal oxaliplatin 750 mg was administered. The patient was discharged with no postoperative complications and has been well with postoperative FOLFOX chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19222104      PMCID： PMC2653448          DOI： 10.3748/wjg.15.756

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  11 in total

1.  Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.

Authors:  R P McQuellon; B W Loggie; R A Fleming; G B Russell; A B Lehman; T D Rambo
Journal:  Eur J Surg Oncol       Date:  2001-02       Impact factor: 4.424

Review 2.  Management of pseudomyxoma peritonei.

Authors:  Zhi-Bo Qu; Lian-Xin Liu
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.

Authors:  B W Loggie; R A Fleming; R P McQuellon; G B Russell; K R Geisinger
Journal:  Am Surg       Date:  2000-06       Impact factor: 0.688

4.  Lessons learned from initial experience with peritonectomy and intra-peritoneal chemotherapy infusion.

Authors:  M Teo; K F Foo; W H Koo; L T Wong; K C Soo
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

5.  Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.

Authors:  Dominique Elias; Emmanuel Benizri; Daniela Di Pietrantonio; Paola Menegon; David Malka; Bruno Raynard
Journal:  Ann Surg Oncol       Date:  2006-11-10       Impact factor: 5.344

6.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

7.  Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination.

Authors:  Faheez Mohamed; David Chang; Paul H Sugarbaker
Journal:  J Surg Oncol       Date:  2003-05       Impact factor: 3.454

8.  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Authors:  Andrew L Feldman; Steven K Libutti; James F Pingpank; David L Bartlett; Tatiana H Beresnev; Sharon M Mavroukakis; Seth M Steinberg; David J Liewehr; David E Kleiner; H Richard Alexander
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

9.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?

Authors:  Tristan D Yan; David L Morris
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

10.  Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  O Glehen; E Cotte; V Schreiber; A C Sayag-Beaujard; J Vignal; F N Gilly
Journal:  Br J Surg       Date:  2004-06       Impact factor: 6.939
View more
  5 in total

1.  Surgical techniques of laparoscopic peritonectomy plus paraaortic lymph node dissection for the treatment of patients with positive lymph node metastasis and peritoneal seeding from rectosigmoid cancer.

Authors:  Jin-Tung Liang
Journal:  Surg Endosc       Date:  2012-01-20       Impact factor: 4.584

2.  Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites.

Authors:  Mingchen Ba; Hui Long; Xiangliang Zhang; Yunqiang Tang; Yinbing Wu; Feihong Yu; Shuai Wang; Shuzhong Cui
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-22       Impact factor: 4.553

3.  Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study.

Authors:  Mingchen Ba; Shuzhong Cui; Hui Long; Yuanfeng Gong; Yinbing Wu; Kunpeng Lin; Yinuo Tu; Bohuo Zhang; Wanbo Wu
Journal:  Front Oncol       Date:  2021-08-06       Impact factor: 6.244

4.  Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites.

Authors:  Ming-Chen Ba; Hui Long; Shu-Zhong Cui; Yun-Qiang Tang; Yin-Bing Wu; Xiang-Liang Zhang; Hong-Sheng Tang; Sai-Xi Bai
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

5.  Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study.

Authors:  Mingchen Ba; Cheng Chen; Hui Long; Yuanfeng Gong; Yinbin Wu; Kunpeng Lin; Yinuo Tu; Bohuo Zhang; Wanbo Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.